黄斑浮腫・黄斑変性治療薬の世界市場予測および分析...市場調査レポートについてご紹介

【英文タイトル】PharmaPoint: Macular Edema and Macular Degeneration - Global Drug Forecast and Market Analysis to 2023

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 10
1.1 List of Tables 17
1.2 List of Figures 23
2 Introduction 27
2.1 Related Reports 28
3 Disease Overview 29
3.1 Macular Degeneration Overview 29
3.1.1 Etiology and Pathophysiology 31
3.1.2 Classification 35
3.1.3 Symptoms and Diagnosis 37
3.2 Macular Edema Overview 40
3.2.1 Etiology and Pathophysiology 41
3.2.2 Classification 44
3.2.3 Symptoms and Diagnosis 45
4 Epidemiology – Macular Edema 48
4.1 Disease Background 48
4.2 Risk Factors and Comorbidities 48
4.3 Global Trends 49
4.3.1 US 50
4.3.2 5EU 50
4.3.3 Japan 51
4.4 Forecast Methodology 51
4.4.1 Sources Used 52
4.4.2 Sources Not Used 54
4.4.3 Forecast Assumptions and Methods — Diagnosed Prevalent Cases of Diabetes 55
4.4.4 Forecast Assumptions and Methods — Diagnosed Prevalent Cases of Diabetic Retinopathy 59
4.4.5 Forecast Assumptions and Methods – Diagnosed Prevalent Cases of DME in the Diagnosed Diabetic Retinopathy Population 60
4.4.6 Forecast Assumptions and Methods – Total Prevalent Cases of ME following BRVO and CRVO 61
4.5 Epidemiological Forecast for Macular Edema (2013-2023) 62
4.5.1 Diagnosed Prevalent Cases of DME in the Diagnosed Diabetic Retinopathy Population 62
4.5.2 Age-Specific Diagnosed Prevalent Cases of DME in the Diagnosed Diabetic Retinopathy Population 64
4.5.3 Sex-Specific Diagnosed Prevalent Cases of DME in the Diagnosed Diabetic Retinopathy Population 66
4.5.4 Total Prevalent Cases of ME Following BRVO 68
4.5.5 Age-Specific Total Prevalent Cases of ME Following BRVO 70
4.5.6 Sex-Specific Total Prevalent Cases of ME following BRVO 72
4.5.7 Total Prevalent Cases of ME Following CRVO 74
4.5.8 Age-Specific Total Prevalent Cases of ME Following CRVO 76
4.5.9 Sex-Specific Total Prevalent Cases of ME Following CRVO 78
4.6 Discussion 80
4.6.1 Epidemiological Forecast Insight 80
4.6.2 Limitations of the Analysis 81
4.6.3 Strengths of the Analysis 82
5 Epidemiology – Age-Related Macular Degeneration 83
5.1 Disease Background 83
5.2 Risk Factors and Comorbidities 84
5.3 Global Trends 85
5.3.1 US 85
5.3.2 5EU 86
5.3.3 Japan 86
5.4 Forecast Methodology 87
5.4.1 Sources Used 88
5.4.2 Forecast Assumptions and Methods 90
5.5 Epidemiological Forecast for AMD (2013-2023) 94
5.5.1 Total Prevalent Cases of AMD 94
5.5.2 Age-Specific Total Prevalent Cases of AMD 95
5.5.3 Sex-Specific Total Prevalent Cases of AMD 97
5.5.4 Age-Standardized Total Prevalence of AMD 99
5.5.5 Total Prevalent Cases of AMD by Stage 101
5.5.6 Total Prevalent Cases of Late AMD by Subtype 102
5.6 Discussion 104
5.6.1 Epidemiological Forecast Insight 104
5.6.2 Limitations of the Analysis 105
5.6.3 Strengths of the Analysis 106
6 Disease Management 107
6.1 Diagnosis and Treatment Overview 107
6.1.1 Macular Edema Diagnosis 107
6.1.2 Macular Degeneration Diagnosis 107
6.1.3 Treatment Guidelines and Leading Prescribed Drugs 108
6.1.4 Clinical Practice 110
6.2 US 123
6.3 France 127
6.4 Germany 130
6.5 Italy 133
6.6 Spain 136
6.7 UK 139
6.8 Japan 142
7 Competitive Assessment 145
7.1 Overview 145
7.2 Product Profiles – Major Brands 146
7.2.1 Lucentis (ranibizumab) 146
7.2.2 Eylea (aflibercept) 157
7.2.3 Avastin (bevacizumab) 168
7.2.4 Macugen (pegaptanib sodium) 175
7.2.5 Visudyne (verteporfin) 178
7.2.6 Corticosteroid Implants 183
8 Unmet Need and Opportunity 195
8.1 Overview 195
8.2 Treatment for Dry AMD 196
8.2.1 Unmet Need 196
8.2.2 Gap Analysis 198
8.2.3 Opportunity 200
8.3 Longer-Acting Anti-VEGF Drug Therapy 202
8.3.1 Unmet Need 202
8.3.2 Gap Analysis 204
8.3.3 Opportunity 204
8.4 Increased Efficacy of Anti-VEGF Therapy for wAMD 205
8.4.1 Unmet Need 205
8.4.2 Gap Analysis 206
8.4.3 Opportunity 207
8.5 Less Invasive Drug Formulations 207
8.5.1 Unmet Need 207
8.5.2 Gap Analysis 208
8.5.3 Opportunity 209
8.6 Awareness and Earlier Patient Diagnosis 210
8.6.1 Unmet Need 210
8.6.2 Gap Analysis 211
8.6.3 Opportunity 211
8.7 Home Monitoring of AMD Progression 212
8.7.1 Unmet Need 212
8.7.2 Gap Analysis 213
8.7.3 Opportunity 214
9 Pipeline Assessment 216
9.1 Overview 216
9.2 Clinical Trial Mapping 217
9.3 Promising Drugs in Clinical Development 218
9.3.1 Abicipar pegol 220
9.3.2 Fovista 227
9.3.3 Squalamine 235
9.3.4 Lampalizumab 243
9.3.5 Emixustat 250
9.3.6 Optina 257
9.3.7 DE-102 265
9.4 Promising Drugs in Early-Stage Development 269
9.4.1 Complement Inhibitors 269
9.5 Other Drugs in Development 271
9.6 Biosimilars 273
10 Current and Future Players 275
10.1 Overview 275
10.2 Trends in Corporate Strategy 277
10.3 Company Profiles 278
10.3.1 Roche/Genentech 278
10.3.2 Novartis 282
10.3.3 Regeneron 285
10.3.4 Bayer 289
10.3.5 Valeant 293
10.3.6 Allergan 296
10.3.7 Alimera Sciences 299
10.3.8 Ampio Pharmaceuticals 303
10.3.9 Ophthotech 305
10.3.10 Acucela 309
10.3.11 Ohr Pharmaceuticals 313
11 Market Outlook 316
11.1 Global Markets 316
11.1.1 Forecast 316
11.1.2 Drivers and Barriers – Global Issues 324
11.2 US 327
11.2.1 Forecast 327
11.2.2 Key Events 333
11.2.3 Drivers and Barriers 333
11.3 France 335
11.3.1 Forecast 335
11.3.2 Key Events 341
11.3.3 Drivers and Barriers 341
11.4 Germany 345
11.4.1 Forecast 345
11.4.2 Key Events 350
11.4.3 Drivers and Barriers 350
11.5 Italy 353
11.5.1 Forecast 353
11.5.2 Key Events 360
11.5.3 Drivers and Barriers 360
11.6 Spain 364
11.6.1 Forecast 364
11.6.2 Key Events 369
11.6.3 Drivers and Barriers 369
11.7 UK 372
11.7.1 Forecast 372
11.7.2 Key Events 378
11.7.3 Drivers and Barriers 378
11.8 Japan 382
11.8.1 Forecast 382
11.8.2 Key Events 388
11.8.3 Drivers and Barriers 388
12 Appendix 392
12.1 Bibliography 392
12.2 Abbreviations 427
12.3 Methodology 434
12.4 Forecasting Methodology 434
12.4.1 Diagnosed ME and AMD Patients 434
12.4.2 Percentage of Drug-Treated Patients 435
12.4.3 Drugs Included in Each Therapeutic Class 435
12.4.4 Launch and Patent Expiry Dates 435
12.4.5 General Pricing Assumptions 436
12.4.6 Individual Drug Assumptions 437
12.4.7 Pricing of Pipeline Agents 442
12.5 Primary Research – KOLs Interviewed for this Report 443
12.6 Primary Research – High-Prescribers Survey 444
12.7 About the Authors 445
12.7.1 Analyst 445
12.7.2 Therapy Area Director 445
12.7.3 Epidemiologist 446
12.7.4 Global Head of Healthcare 446
12.8 About GlobalData 447
12.9 Disclaimer 447


【レポート販売概要】

■ タイトル:黄斑浮腫・黄斑変性治療薬の世界市場予測および分析
■ 英文:PharmaPoint: Macular Edema and Macular Degeneration - Global Drug Forecast and Market Analysis to 2023
■ 発行日:2014年10月31日
■ 調査会社:GlobalData
■ 商品コード:GDHC111PIDR
■ 調査対象地域:グローバル
  • 内燃機関の世界市場2017-2021
    About Internal Combustion Engine Various types of combustion engines were developed and tested during the second half of the 19th century. In the following decade, many such engines were produced with a power delivery of 6 HP and efficiency around 5%. This was followed by the introduction of the Otto-Langen engines in 1867 with enhanced efficiency up to 10%. It was during this time that the basic …
  • Neurodegenerative Diseases Market to 2018 – New Product Entries in both Niche and Broader Parkinson’s Disease Treatment will Boost Market Despite Patent Cliff
    Neurodegenerative Diseases Market to 2018 - New Product Entries in both Niche and Broader Parkinson’s Disease Treatment will Boost Market Despite Patent Cliff Summary GBI Research, the leading business intelligence provider, has released its latest research “Neurodegenerative Diseases Market to 2018 - New Product Entries in both Niche and Broader Parkinson’s Disease Treatment will Boost Market Des …
  • 月経カップの世界市場:使い捨て、再利用可能
    The global menstrual cup market accounted for around $1,213 million in 2018 and is expected to reach $1,894 million by 2026, registering a CAGR of 5.7% from 2019 to 2026. A menstrual cup is a feminine hygiene product that are used during menstruation. It is inserted into the vagina and one can keep it inside for maximum 12 hours. Its purpose is to prevent menstrual blood from leaking onto the clot …
  • 細胞培養製品の世界市場:試薬、培地、血清、細胞自動培養装置、バイオリアクター、遠心分離機、フローサイトメーター、インキュベーター等
    The global cell expansion market is expected to reach $14.8 billion by 2019 from $6.0 billion in 2014, growing at a CAGR of 19.7% from 2014 to 2019. The global cell expansion market is categorized on the basis of product, cell type, application, end user, and geography. The human cell expansion segment is expected to register the highest growth rate in the cell expansion market, by cell type, duri …
  • 世界の主要コネクティッド・カー製造企業動向2014
    In 2014, the Connected Car market is dominated by OEM embedded in-car connectivity solutions and Aftermarket telematics hardware providers. However, the market is experiencing the entrance of new players, including telecom, internet giants who are competing to win new customers as in-car connectivity becomes a significant selling point. At the same time global regulatory mandates, such as the eCal …
  • 2Dパーコードリーダーの世界市場:種類別(携帯型、固定型)、用途別(トラッキング・マーケティング、図書館、駐車場、小売業)、地域別予測
    Global 2D Barcode Reader Market to reach USD XXX billion by 2025. Global 2D Barcode Reader Market valued approximately USD XXX billion in 2016 is forecasted to grow with a healthy growth rate of more than XX% over the forecast period 2018-2025. The major factors anticipated augmenting the market are the proficiency of 2D Barcode Reader to adapt an enormous size of information and increased accepta …
  • データセンターインフラ管理(DCIM)の世界市場2016-2020
    About DCIM Solutions A DCIM solution is a comprehensive software solution that addresses major issues in the data center environment such as computing resource management (CRM), powering and cooling, asset management, IT management, and monitoring. DCIM solutions enable IT managers to efficiently manage and maintain the performance of data center infrastructure in an enterprise and also increases …
  • 中東(GCC)のセメント市場
    Technavio’s market research analyst has estimated the cement market in the GCC to post a healthy market growth rate of more than 6% during the forecast period. The rise in population, increase in tourists, demand for affordable houses, and the development of new cities are some of the factors that are expected to propel market growth during the forecast period. Augmented investments in the transpo …
  • 世界の自動車センタースタック市場動向(2012-2016)
    TechNavio's analysts forecast the Global Automotive Center Stack market to grow at a CAGR of 3.57 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in automotive production and sales. The market has also been witnessing increasing demand for by-wire technologies. However, issues related to system integration could pose a challenge to the g …
  • 世界の小売業界におけるGIS市場動向(2012-2016)
    TechNavio's analysts forecast the GIS market in the Retail industry to grow at a CAGR of 18.55 percent over the period 2012-2016. One of the key factors contributing to this market growth is the need to understand customer demographics and buying patterns. The GIS market in the Retail industry has also been witnessing the increasing adoption of GIS applications in mobile computing devices. However …
  • Mobile Commerce in Industry Verticals
    This report provides an understanding of m-commerce in major industries including market impact and revenue potential. This research evaluates market opportunities for mobile commerce for major industry verticals and forecasts to 2017. The report analyzes market dynamics of specific regions and countries and examines current applications and forecasts developments for 2012 to 2017.
  • 発現ベクターの世界市場:細菌発現ベクター、哺乳類発現ベクター、昆虫発現ベクター、酵母発現ベクター
    The expression vectors market is expected to reach $317.1 million by 2020 from $242.7 million in 2015, growing at a CAGR of 5.5% from 2015 to 2020. The market is categorized on the basis of host type, application, end user, and region. The application market includes therapeutic, research, and industrial applications. The therapeutic applications segment is expected to grow at the highest CAGR in …
  • Google Update April 2010
    The Google Update report provides timely analysis and projections about Google market prospects, products and applications, product and company integration, current and potential mergers and acquisitions, and more. Google Patent for Location-based Advertisements: One of the most important benefits of this edition of Google Update is a full analysis of the Google patent for location-based advertisi …
  • 締固め機械の世界市場2017-2021
    About Compaction EquipmentA compactor is a machine or mechanism used to reduce the thickness of materials such as soil, aggregates, concrete, and so on by filling the air voids present in the material. Technavio’s analysts forecast the global Compaction Equipment market to grow at a CAGR of 4.74% during the period 2017-2021. [Covered in this report] The report covers the present scenario and the g …
  • Namenda XR (Alzheimer’s Disease):市場予測と分析(~2022)
    Namenda XR (Alzheimer’s Disease) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Namenda XR (Alzheimer’s Disease) - Forecast and Market Analysis to 2022”. There are no long-term effective therapies for Alzheimer’s Disease (AD), so this remains at the top of the list for unmet needs. While physicians agree that symptomatic therapie …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。